Literature DB >> 2193636

Effects of androgen treatment in impotent men with normal and low levels of free testosterone.

C Carani1, D Zini, A Baldini, L Della Casa, A Ghizzani, P Marrama.   

Abstract

The relation between sexual function and serum free testosterone (fT) levels, which represent the active fraction of circulating testosterone, was evaluated. Two groups of impotent male subjects with mild hypogonadism were treated with oral testosterone undecanoate (TU); these men presented with tT/luteinizing hormone (LH) ratio and tT levels at the lower limits of normal. The first group had serum fT below 6.6 ng/ml, considered the lower normal value, according to our laboratory method, whereas the second group had normal fT limits. Administration of TU improved sexual function only in impotent men with low fT levels, but not in subjects with normal fT levels, even though the tT levels and the tT/LH ratio of the two groups were not significantly different. The results of our study suggest the presence of a minimum serum fT threshold, lying near the lower normal range, which determines the male sexual function. Moreover, serum fT levels were a more sensitive index than tT for identifying impotent men who can be successfully treated with androgens.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2193636     DOI: 10.1007/bf01541548

Source DB:  PubMed          Journal:  Arch Sex Behav        ISSN: 0004-0002


  19 in total

1.  Androgens and male sexual function: a review of human studies.

Authors:  R C Schiavi; D White
Journal:  J Sex Marital Ther       Date:  1976

2.  Hormonal changes and sexual function in aging men.

Authors:  J M Davidson; J J Chen; L Crapo; G D Gray; W J Greenleaf; J A Catania
Journal:  J Clin Endocrinol Metab       Date:  1983-07       Impact factor: 5.958

3.  Changes in erectile responsiveness during androgen replacement therapy.

Authors:  J Bancroft; F C Wu
Journal:  Arch Sex Behav       Date:  1983-02

4.  The behavioural effects of testosterone undecanoate in adult men with Klinefelter's syndrome: a controlled study.

Authors:  F C Wu; J Bancroft; D W Davidson; K Nicol
Journal:  Clin Endocrinol (Oxf)       Date:  1982-05       Impact factor: 3.478

5.  Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study.

Authors:  N E Skakkebaek; J Bancroft; D W Davidson; P Warner
Journal:  Clin Endocrinol (Oxf)       Date:  1981-01       Impact factor: 3.478

6.  Serum testosterone concentration and penile tumescence changes in men.

Authors:  J D Lange; W A Brown; J P Wincze; W Zwick
Journal:  Horm Behav       Date:  1980-09       Impact factor: 3.587

7.  The relationship between men's endogenous levels of testosterone and their penile responses to erotic stimuli.

Authors:  H B Rubin; D E Henson; R E Falvo; R W High
Journal:  Behav Res Ther       Date:  1979

8.  Serum testosterone and sexual activity and interest in men.

Authors:  W A Brown; P M Monti; D P Corriveau
Journal:  Arch Sex Behav       Date:  1978-03

9.  Clinical efficacy of testosterone undecanoate in male hypogonadism.

Authors:  N M Maisey; J Bingham; V Marks; J English; J Chakraborty
Journal:  Clin Endocrinol (Oxf)       Date:  1981-06       Impact factor: 3.478

10.  Double-blind group comparative study of testosterone undecanoate and mesterolone in hypogonadal male patients.

Authors:  M Luisi; F Franchi
Journal:  J Endocrinol Invest       Date:  1980 Jul-Sep       Impact factor: 4.256

View more
  4 in total

Review 1.  The role of testosterone in erectile dysfunction.

Authors:  Giovanni Corona; Mario Maggi
Journal:  Nat Rev Urol       Date:  2009-12-08       Impact factor: 14.432

Review 2.  Hormonal aspects of sexual dysfunction: the therapeutic use of exogenous androgens in men and women.

Authors:  S N Seidman
Journal:  Curr Psychiatry Rep       Date:  2000-06       Impact factor: 5.285

Review 3.  Effect of androgens on penile tissue.

Authors:  Ronald W Lewis; Thomas M Mills
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

Review 4.  Prosexual drugs: empirical status of the "new aphrodisiacs".

Authors:  R C Rosen; A K Ashton
Journal:  Arch Sex Behav       Date:  1993-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.